Haloperidol Metabolite II Valproate Ester (S)-(−)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma-Reference-Cited by-同舟云学术

Haloperidol Metabolite II Valproate Ester (S)-(−)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma

Published:2021-09-03 Issue:18 Volume:64 Page:13622-13632
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Barbaraci Carla¹²^ORCID,Giurdanella Giovanni³,Leotta Claudia Giovanna²,Longo Anna³,Amata Emanuele¹^ORCID,Dichiara Maria¹,Pasquinucci Lorella¹^ORCID,Turnaturi Rita¹^ORCID,Prezzavento Orazio¹^ORCID,Cacciatore Ivana⁴^ORCID,Zuccarello Elisa⁵,Lupo Gabriella³,Pitari Giovanni Mario²^ORCID,Anfuso Carmelina Daniela³,Marrazzo Agostino¹^ORCID

Affiliation:

1. Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy

2. Vera Salus Ricerca S.r.l., Via Sigmund Freud 62/B, 96100 Siracusa, Italy

3. Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Via S. Sofia 97, 95123 Catania, Italy

4. Department of Pharmacy, “G. D’Annunzio” University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti Scalo, Italy

5. Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University, New York, New York 10032, United States

Funder

Ministero dell???Istruzione, dell???Universit?? e della Ricerca

European Regional Development Fund

European Social Fund

Vera Salus Ricerca S.r.l.

Publisher